PMID- 31447346 OWN - NLM STAT- MEDLINE DCOM- 20191007 LR - 20191007 IS - 1769-6658 (Electronic) IS - 1278-3218 (Linking) VI - 23 IP - 6-7 DP - 2019 Oct TI - Do all the linear accelerators comply with the ICRU 91's constraints for stereotactic body radiation therapy treatments? PG - 625-629 LID - S1278-3218(19)30313-0 [pii] LID - 10.1016/j.canrad.2019.07.137 [doi] AB - Recent technological developments in linear accelerators (linacs) and their imaging systems have made it possible to routinely perform stereotactic radiotherapy (SRT) treatments. To ensure the security and quality of the treatments, national and international recommendations have been written. This review focuses on the recommendations of the report 91 of the International Commission on Radiation Units (ICRU) on stereotactic treatments with small photon beams and proposes to answer the question of the eligibility of the commercially available accelerators for the treatment of extra-cranial SRT (SBRT). The ICRU 91 report outlines important features needed to respect the constraints, which are high intensity photon beam, integrated image-guidance, high mechanical accuracy of the linac, multileaf collimator with reduced leaf width, bundled motion management and bundled 6 Dimensional "robotic" couch tabletop. Most of the contemporary linacs meet these recommendations, in particular, stereotactic dedicated linacs, or modern gantry-based linacs equipped with 3 dimensional cone-beam CT imaging and 2D-stereoscopic planar imaging. Commercially available ring-based linacs have some limitations: they offer only coplanar treatments, and couch movements are limited to translations and, some have limited imaging equipment and no ability to manage intrafraction motion. However, for performing SBRT, non-coplanar irradiations are not mandatory, contrarily to intracranial stereotactic irradiations. Furthermore, patients' rotations can be corrected, thanks to real-time adaptive radiotherapy available on MRI-linacs. Finally, significant improvements are expected in the short term to compensate the weaknesses of the current devices. CI - Copyright (c) 2019 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved. FAU - Biston, M C AU - Biston MC AD - Leon Berard Cancer Center, University of Lyon, 69373 Lyon, France; Universite de Lyon, CREATIS, CNRS UMR5220, Inserm U1044, INSA, 69622 Lyon, France. Electronic address: marie-claude.biston@lyon.unicancer.fr. FAU - Dupuis, P AU - Dupuis P AD - Leon Berard Cancer Center, University of Lyon, 69373 Lyon, France. FAU - Gassa, F AU - Gassa F AD - Leon Berard Cancer Center, University of Lyon, 69373 Lyon, France. FAU - Gregoire, V AU - Gregoire V AD - Leon Berard Cancer Center, University of Lyon, 69373 Lyon, France. LA - eng PT - Journal Article PT - Review DEP - 20190822 PL - France TA - Cancer Radiother JT - Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique JID - 9711272 SB - IM MH - Equipment Design/standards MH - *Guideline Adherence MH - Humans MH - Immobilization/instrumentation MH - International Agencies/*standards MH - Neoplasms/*radiotherapy MH - Particle Accelerators/*standards MH - Photons/therapeutic use MH - Quality Assurance, Health Care MH - Radiosurgery/*instrumentation/methods/standards MH - Radiotherapy, Image-Guided/standards OTO - NOTNLM OT - ICRU 91 OT - SBRT EDAT- 2019/08/27 06:00 MHDA- 2019/10/08 06:00 CRDT- 2019/08/27 06:00 PHST- 2019/07/02 00:00 [received] PHST- 2019/07/11 00:00 [accepted] PHST- 2019/08/27 06:00 [pubmed] PHST- 2019/10/08 06:00 [medline] PHST- 2019/08/27 06:00 [entrez] AID - S1278-3218(19)30313-0 [pii] AID - 10.1016/j.canrad.2019.07.137 [doi] PST - ppublish SO - Cancer Radiother. 2019 Oct;23(6-7):625-629. doi: 10.1016/j.canrad.2019.07.137. Epub 2019 Aug 22.